Download App

Log in to access Online Inquiry
Company Overview More
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company’s therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. It has a collaboration agreement with MolGenie GmbH to discover and develop anti-viral drug candidates against COVID-19. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.
CEO: Kumar Ph.D., Amit
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Moomoo > Quotes > ANIX Anixa Biosciences > Detailed Quotes

ANIX Anixa Biosciences

3.320-0.070-2.06%
Close 05/18 20:00 ET
3.32000.00%
Post Mkt Price 05/18 16:31 ET
High
3.540
Open
3.310
Turnover
539.29K
Low
3.240
Pre Close
3.390
Volume
160.00K
Market Cap
100.11M
P/E(TTM)
Loss
52wk High
5.870
Shares
30.15M
P/E(Static)
Loss
52wk Low
2.300
Float Cap
94.67M
Bid/Ask %
-86.67%
Historical High
8.950
Shs Float
28.51M
Volume Ratio
2.11
Historical Low
0.056
Dividend TTM
--
Div Yield TTM
800
P/B
2.95
Dividend LFY
--
Div Yield LFY
24096.39%
Turnover Ratio
0.56%
Amplitude
8.85%
Avg Price
3.370
Lot Size
1
Float Cap
94.67M
Bid/Ask %
-86.67%
Historical High
8.950
Shs Float
28.51M
Volume Ratio
2.11
Historical Low
0.056
Dividend TTM
--
P/B
2.95
Dividend LFY
--
Turnover Ratio
0.56%
Amplitude
8.85%
Avg Price
3.370
Lot Size
1
Price Forecast

No Data

News

Comment